78 related articles for article (PubMed ID: 17072347)
1. Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions.
Nanjundan M; Zhang F; Schmandt R; Smith-McCune K; Mills GB
Oncogene; 2007 Apr; 26(18):2574-84. PubMed ID: 17072347
[TBL] [Abstract][Full Text] [Related]
2. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
3. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis.
Leung YK; Lau KM; Mobley J; Jiang Z; Ho SM
Cancer Res; 2005 May; 65(9):3726-34. PubMed ID: 15867368
[TBL] [Abstract][Full Text] [Related]
5. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
[TBL] [Abstract][Full Text] [Related]
6. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer.
Mok SC; Chan WY; Wong KK; Cheung KK; Lau CC; Ng SW; Baldini A; Colitti CV; Rock CO; Berkowitz RS
Oncogene; 1998 May; 16(18):2381-7. PubMed ID: 9620555
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional characterization of a novel unspliced transcript variant of HIC-1 in human cancer cells exposed to adverse growth conditions.
Mondal AM; Chinnadurai S; Datta K; Chauhan SS; Sinha S; Chattopadhyay P
Cancer Res; 2006 Nov; 66(21):10466-77. PubMed ID: 17079468
[TBL] [Abstract][Full Text] [Related]
9. [The effects of different transcripts of AML1 on the transactivation of M-CSF-R gene].
Zhang Q; Wang M; Xing HY; Rao Q; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):641-4. PubMed ID: 16620545
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, characterization and isolation of novel spliced variants of the human ortholog of a rat estrogen-regulated membrane-associated protein, UO-44.
Leong CT; Ng CY; Ong CK; Ng CP; Ma ZS; Nguyen TH; Tay SK; Huynh H
Oncogene; 2004 Jul; 23(33):5707-18. PubMed ID: 15184879
[TBL] [Abstract][Full Text] [Related]
12. Structure of the bovine VASAP-60/PRKCSH gene, functional analysis of the promoter, and gene expression analysis.
Brûlé S; Sayasith K; Sirois J; Silversides DW; Lussier JG
Gene; 2007 Apr; 391(1-2):63-75. PubMed ID: 17250974
[TBL] [Abstract][Full Text] [Related]
13. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
14. Activin is a potent growth suppressor of epithelial ovarian cancer cells.
Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN
Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612
[TBL] [Abstract][Full Text] [Related]
15. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.
Turner JD; Schote AB; Keipes M; Muller CP
Ann N Y Acad Sci; 2007 Jan; 1095():334-41. PubMed ID: 17404046
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
Treeck O; Pfeiler G; Mitter D; Lattrich C; Piendl G; Ortmann O
J Endocrinol; 2007 Jun; 193(3):421-33. PubMed ID: 17535880
[TBL] [Abstract][Full Text] [Related]
17. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
18. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.
Di Benedetto M; Bièche I; Deshayes F; Vacher S; Nouet S; Collura V; Seitz I; Louis S; Pineau P; Amsellem-Ouazana D; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Lidereau R; Nahmias C
Gene; 2006 Oct; 380(2):127-36. PubMed ID: 16887298
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E suppresses telomerase activity in ovarian cancer cells.
Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
